DUBLIN, Mar 24, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Blood Glucose Monitoring Devices Market 2017-2021" report to their offering.
The global blood glucose monitoring devices market to grow at a CAGR of 11.81% during the period 2017-2021.
The report, Global Blood Glucose Monitoring Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.
One trend in market is smart watch-based apps. The Dexcom CGM and its mobile apps Follow and Share 2 are the first mobile-connected systems approved by the US FDA. This device allows users to directly view the glucose data on their iPhone. Currently, Dexcom provides its devices G4 platinum CGM with Share that supports the Apple watch. Along with this, the users can invite up to five people to view their glucose information, and an alert message can be sent when the user's glucose levels are above normal range. This is a significant breakthrough in diabetes management. The use of glucose meters is supplemented by CGM devices in diabetes management. Meters still play a major role in calibrating CGM devices and in guiding therapy and meal decisions. In addition to providing the glucose levels, CGM devices provide the direction and rate of change in glucose levels with the push of a button and alerts users when the glucose level is too low or too high.
According to the report, one driver in market is growing prevalence of diabetes in the world. In 2015, approximately 415 million people in the world had diabetes, which is expected to increase to around 642 million by 2040. As of 2015, it has been estimated that 9.1% adults in the world have diabetes and this is expected to increase to 10% by 2040. In addition, 75%-80% of the individuals with diabetes belonged to low- and middle-income countries. The number of people with diabetes is high in APAC. According to OECD, the prevalent cases are going to reach about 47,973,000 in Europe, 66,812,000 in the Americas, and 18,234,000 in Africa by 2030. The global prevalence of diabetes was estimated to be 9% among adults aged above 18 years.
- Abbott Laboratories
- Roche Diagnostics
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by product
PART 07: Market segmentation by end-user
PART 08: Geographical segmentation
PART 09: Market drivers
PART 10: Impact of drivers
PART 11: Market challenges
PART 12: Impact of drivers and challenges
PART 13: Market trends
PART 14: Vendor landscape
PART 15: Key vendor analysis
PART 16: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/nw9cvh/global_blood
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-blood-glucose-monitoring-devices-market-to-grow-at-a-cagr-of-118-by-2021---increased-adoption-of-bundled-product-marketing-strategy---research-and-markets-300428997.html
SOURCE Research and Markets